Pfizer chairman talks about how they will impact cancer patients

2 months ago
49

Pfizer's chairman and CEO, Albert Bourla, stated regarding the acquisition of Seagen and its focus on oncology, "Seagen acquisition and oncology. It is what it is - our new Covid. I think will be blockbuster drugs... they will have significant impact on cancer patients."

Loading 1 comment...